astragaloside a has been researched along with Anoxemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 7 (87.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, A; Li, C; Li, G; Li, S; Meng, F; Wu, S; Zha, J; Zhang, S; Zhu, H; Zhu, L | 1 |
| Feng, Y; Gao, X; Hao, X; Li, L; Long, Y; Zhang, J; Zhang, S; Zhang, X | 1 |
| Liu, Y; Lu, ML; Tang, BL; Wang, HX | 1 |
| Li, R; Liu, D; Ma, Y; Xi, J | 1 |
| Jin, CT; Jin, HQ; Jin, YC; Liu, YM; Yang, YX; Ying, MF; Zhao, R | 1 |
| Bai, XH; Chen, JK; Chen, LQ; Guo, MK; Li, JQ; Li, L; Su, SM | 1 |
| Chen, Y; Han, M; Jiang, S; Jiao, G; Liu, W; Wang, X | 1 |
| Liu, Q; Liu, Y; Wang, D; Wang, Y; Yan, X; Zhang, T; Zhao, Z; Zhong, G | 1 |
8 other study(ies) available for astragaloside a and Anoxemia
| Article | Year |
|---|---|
Astragaloside IV ameliorates pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension by restraining the T follicular helper cell response and expanding T follicular regulatory cell response.
Topics: Animals; Hypertension, Pulmonary; Hypoxia; Mice; Pulmonary Artery; Quality of Life; Saponins; Sildenafil Citrate; T Follicular Helper Cells; Triterpenes; Vascular Remodeling | 2022 |
Astragaloside IV in Hypoxic Pulmonary Hypertension: an In Vivo and In Vitro Experiments.
Topics: Animals; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Monocrotaline; Rats; Saponins; Tumor Necrosis Factor-alpha | 2022 |
Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathway.
Topics: Animals; Disease Models, Animal; Endothelial Cells; Epidermal Growth Factor; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Hypoxia; Male; MAP Kinase Signaling System; Oxygen; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 2023 |
Astragaloside IV restrains pyroptosis and fibrotic development of pulmonary artery smooth muscle cells to ameliorate pulmonary artery hypertension through the PHD2/HIF1α signaling pathway.
Topics: Animals; Cell Proliferation; Fibrosis; Hypertension, Pulmonary; Hypoxia; Myocytes, Smooth Muscle; Prolyl Hydroxylases; Pulmonary Arterial Hypertension; Pulmonary Artery; Pyroptosis; Rats; Signal Transduction | 2023 |
Astragaloside IV protects cardiomyocytes from hypoxic injury by regulating endoplasmic reticulum stress via eIF2α/CHOP signaling pathway.
Topics: Apoptosis; Caspase 3; Caspase 9; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Humans; Hypoxia; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Signal Transduction | 2023 |
Astragaloside IV ameliorates intermittent hypoxia-induced inflammatory dysfunction by suppressing MAPK/NF-κB signalling pathways in Beas-2B cells.
Topics: Cells, Cultured; Humans; Hypoxia; Inflammation; Lung; MAP Kinase Signaling System; NF-kappaB-Inducing Kinase; Protein Serine-Threonine Kinases; Respiratory Mucosa; Saponins; Sleep Apnea, Obstructive; Triterpenes | 2020 |
Astragaloside IV attenuates chronic intermittent hypoxia-induced myocardial injury by modulating Ca
Topics: Animals; Apoptosis; Calcium; Echocardiography; Fibrosis; Heart; Homeostasis; Hypoxia; Male; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Saponins; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sleep Apnea, Obstructive; Triterpenes | 2020 |
Compatibility of Tanshinone IIA and Astragaloside IV in attenuating hypoxia-induced cardiomyocytes injury.
Topics: Abietanes; Animals; Apoptosis; Cell Line; Cell Movement; Cell Survival; Cells, Cultured; Chemokines; Hypoxia; L-Lactate Dehydrogenase; Macrophages, Peritoneal; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Rats; RNA, Messenger; Saponins; Triterpenes | 2017 |